| Financial Year |
March 31 2023 |
| Monetary Funds |
4,251,634,076.26 |
| Held-for-trading Financial Assets |
476,539,997.35 |
| Notes Receivable |
116,562,510.06 |
| Accounts Receivable |
1,977,155,907.35 |
| Advances to Suppliers |
189,065,786.72 |
| Other Receivables |
662,575,730.30 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
6,913,211.87 |
| Dividend Receivable |
-- |
| Inventories |
2,817,443,715.24 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
1,009,778,941.25 |
| Total Current Assets |
11,713,456,167.28 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
2,758,130,666.57 |
| Investment Properties |
742,016,587.84 |
| Fixed Assetes |
7,244,251,925.58 |
| Under-construction Projects |
1,320,740,517.59 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
27,960,807.24 |
| Oil and Gas Assets |
-- |
| Intangible Assets |
1,725,089,533.71 |
| R&D expenses |
27,980,856.57 |
| Goodwill |
2,948,094,492.45 |
| Long-Term Deferred and Prepaid Expenses |
523,303,210.44 |
| Deferred Income Tax Assets |
353,591,907.05 |
| Other Non-Current Assets |
276,733,099.00 |
| Sub-Total of Non-Current Assets |
18,512,102,623.69 |
| Total Assets |
30,225,558,790.97 |
| Short-Term Loans |
4,707,014,954.89 |
| Trading Financial liabilities |
618,559.38 |
| Notes Payable |
1,264,090,017.07 |
| Accounts Payable |
1,262,286,794.89 |
| Accounts Received In Advance |
37,345,377.71 |
| Employee Compensation Payable |
300,110,482.23 |
| Taxes Payable |
329,319,018.08 |
| Interest Payable |
-- |
| Dividend Payable |
6,401,373.32 |
| Other payables |
1,349,202,724.19 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
1,426,967,921.04 |
| Other Current Liabilities |
13,759,936.52 |
| Sub-Total of Current Liabilities |
10,836,183,158.19 |
| Long-term Loans |
1,901,044,812.63 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
194,628,567.77 |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
103,830,269.00 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
2,543,834,845.88 |
| Total Liabilities |
13,380,018,004.07 |
| Paid-In Capital(Or Share Stock) |
1,979,919,191.00 |
| Capital Surplus |
5,251,838,934.55 |
| Surplus Reserve |
505,431,545.28 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
2,724,863,512.63 |
| Minority Stockholder's Interest |
6,477,198,670.47 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
10,368,342,116.43 |
| Owner's Equity（Stockholder's Equity） |
16,845,540,786.90 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
30,225,558,790.97 |
